OtherChemotherapy, Antibiotics, and Gene Therapy
Repression of Mitogen-Activated Protein Kinase (MAPK) Phosphatase-1 by Anthracyclines Contributes to their Anti- apoptotic Activation of p44/42-MAPK
George W. Small, Sivagurunathan Somasundaram, Dominic T. Moore, Yue Y. Shi and Robert Z. Orlowski
Journal of Pharmacology and Experimental Therapeutics October 13, 2003, DOI: https://doi.org/10.1124/jpet.103.055806
George W. Small
Sivagurunathan Somasundaram
Dominic T. Moore
Yue Y. Shi
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherChemotherapy, Antibiotics, and Gene Therapy
Repression of Mitogen-Activated Protein Kinase (MAPK) Phosphatase-1 by Anthracyclines Contributes to their Anti- apoptotic Activation of p44/42-MAPK
George W. Small, Sivagurunathan Somasundaram, Dominic T. Moore, Yue Y. Shi and Robert Z. Orlowski
Journal of Pharmacology and Experimental Therapeutics October 13, 2003, DOI: https://doi.org/10.1124/jpet.103.055806
OtherChemotherapy, Antibiotics, and Gene Therapy
Repression of Mitogen-Activated Protein Kinase (MAPK) Phosphatase-1 by Anthracyclines Contributes to their Anti- apoptotic Activation of p44/42-MAPK
George W. Small, Sivagurunathan Somasundaram, Dominic T. Moore, Yue Y. Shi and Robert Z. Orlowski
Journal of Pharmacology and Experimental Therapeutics October 13, 2003, DOI: https://doi.org/10.1124/jpet.103.055806
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement